Activating Transcription Factor 7 (ATF7) (N-Term) Peptide
-
- Target See all ATF7 products
- ATF7 (Activating Transcription Factor 7 (ATF7))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ATF7 antibody (Catalog #: P100817_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ATF7 (Activating Transcription Factor 7 (ATF7))
- Background
-
The human ATF7(ATFa) proteins belong to the ATF/CREB family of transcription factors.They mediate the transcriptional activation by the largest E1a protein and can heterodimerize with members of the Jun/Fos family. ATFa proteins have also been found tightly associated with JNK2, a stress-activated kinase. Four variants of ATFa (ATFa0, ATFa1, ATFa2, and ATFa3) have been characterized.
Alias Symbols: ATFA, MGC57182
Protein Interaction Partner: YY1,TAF12,TAF4,YY1,ATF2,FOS,MAPK9,PTP4A1,PTP4A2,TAF12,TAF4,JDP2,PTP4A1
Protein Size: 483 - Molecular Weight
- 52 kDa
- Gene ID
- 11016
- NCBI Accession
- NM_006856, NP_006847
- UniProt
- B2RMP1
-